American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), Washington, DC, American Psychiatric Press, 2000.
2.
World Health Organization, International Classification of Diseases and Health-Related Problems, 10th Revision (ICD-10), Geneva, World Health Organization, 1992.
3.
Robertson MM : Tourette syndrome, associated conditions and the complexities of treatment. Brain2000;123:425—462.
4.
Singer HS: Tourette's syndrome: From behaviour to biology. Lancet Neurol2005;4:149—159.
5.
Kadesjo B., Gillberg C.: Tourette's disorder: Epidemiology and comorbidity in primary school children . J Am Acad Child Adolesc Psychiatry2000;39:548—555.
6.
Hornsey H., Banerjee S., Zeitlin H., Robertson M.: The prevalence of Tourette syndrome in 13-14-year-olds in mainstream schools . J Child Psychol Psychiatry2001;42:1035—1039.
7.
Kurlan R., McDermott MP, Deeley C., et al: Prevalence of tics in schoolchildren and association with placement in special education. Neurology2001;57:1383—1388.
8.
Khalifa N., von Knorring AL: Prevalence of tic disorders and Tourette syndrome in a Swedish school population . Dev Med Child Neurol2003;45:315—319.
9.
Lanzi G., Zambrino CA, Termine C., et al: Prevalence of tic disorders among primary school students in the city of Pavia, Italy. Arch Dis Child2004 ;89:45—47.
10.
Wang HS, Kuo MF: Tourette's syndrome in Taiwan: An epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev2003;25(Suppl 1):S29—S31.
11.
Jin R., Zheng RY, Huang WW, et al: Study on the prevalence of Tourette syndrome in children and juveniles aged 7-16 years in Wenzhou area. Zhonghua Liu Xing Bing Xue Za Zhi2004;25: 131—133.
12.
Baron-Cohen S., Mortimore C., Moriarty J., et al: The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism . J Child Psychol Psychiatry1999;40:213—218.
13.
Eapen V., Robertson MM, Zeitlin H., Kurlan R.: Gilles de la Tourette's syndrome in special education schools: A United Kingdom study. J Neurol1997;244:378—382.
14.
Pauls DL: Update on the genetics of Tourette syndrome. Adv Neurol2001;85:281—293.
15.
Pauls DL: An update on the genetics of Gilles de la Tourette syndrome. JPsychosom Res2003;55:7—12.
16.
Leckman JF, Dolnansky ES, Hardin MT, et al: Perinatal factors in the expression of Tourette's syndrome: An exploratory study. J Am Acad Child Adolesc Psychiatry1990;29:220—226.
17.
Leckman JF, Riddle MA: Tourette's syndrome: When habit forming units form habits of their own? Neuron2000;28:349—354.
18.
Robertson MM : The Gilles de la Tourette syndrome; an update . Psychiatry2004;3:3—7.
19.
Robertson MM : Tourette syndrome. Psychiatry2005;4:92—97.
20.
Jankovic J. : Tourette's syndrome. N Engl J Med2001;345:1184— 1192.
21.
Swedo SE, Leonard HL, Garvey M., et al: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry1998;155:264—271.
22.
Swedo SE, Leonard HL, Shapiro MB, et al: Sydenham's chorea: Physical and psychological symptoms of St Vitus dance. Pediatrics1993;91:706—713.
Swedo S., Leonard HL, Kiessling L.: Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics1994;93:323—326.
25.
Murphy TK, Goodman WK, Ayoub EM, Voeller KK: On defining Sydenham's chorea: Where do we draw the line?Biol Psychiatry2000;47:851—857.
26.
Bronze MS, Dale JB: Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol1993;151:2820—2828.
27.
Husby G., Van de Rijn I., Zabriskie JB, et al: Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med1976;144:1094— 1110.
28.
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW: Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea . Nat Med2003;9:914—920.
29.
Robertson MM , Eapen V.: The National Hospital Interview Schedule for the assessment of Gilles de la Tourette syndrome. Int J Methods Psychiatr Res1996;6:203—206.
30.
Leckman JF, Riddle MA, Hardin MT, et al: The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry1989;28:566—573.
31.
Tourette Syndrome Classification Study Group : Definitions and classification of tic disorders. Arch Neurol1993;50:1013—1016.
32.
Scahill L., Riddle MA, Mc-Swiggin-Hardin M., et al: Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. J Am Acad Child Adolesc Psychiatry1997;36:844—852.
33.
Muller N., Kroll B., Schwarz MJ, et al: Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res2001;101:187—193.
34.
Church AJ, Dale RC, Lees AJ, et al: Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry2003;74:602—607.
35.
Kaplan EL, Rothermel CD, Johnson DR: Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States. Pediatrics1998;101:86—88.
36.
Glantz SA: Primer ofBiostatistics, New York, McGraw-Hill, 2002.
37.
Snider LA, Swedo SE: PANDAS: Current status and directions for research. Mol Psychiatry2004;9:900—907.
38.
Kurlan R.: Tourette's syndrome and ``PANDAS'': Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection . Neurology1998;50: 1530—1534.
39.
Dale RC, Candler PM, Church AJ, et al: Glycolytic enzymes on neuronal membranes are candidate autoantigens in post-streptococcal neuropsychiatric disorders. Mov Disord2004;19(Suppl 9): P45, S33.
40.
Brynska A., Wolanczyk T.: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). A report of two cases. Psychiatr Pol2004;38:105—123.
41.
Murphy TK, Sajid M., Soto O., et al: Detecting pediatric autoimmune neuropsychiatric disorder associated with streptococcus in children with obsessive-compulsive disorder and tics . Biol Psychiatry2004;55:61—68.
42.
Kiessling LS , Marcotte AC, Culpepper L.: Antineuronal antibodies in movement disorders . Pediatrics1993;92:39—43.
43.
Muller N., Riedel M., Straube A., et al: Increased anti-streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res2000;94:43—49.
44.
Cardona F., Orefici G.: Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr2001;138: 71—75.
45.
Morshed SA, Parveen S., Leckman JF, et al: Antibodies against neural nuclear, cytoskeletal and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea and autoimmune disorders. Biol Psychiatry2001;50: 566—577.
46.
Peterson BS, Leckman JF, Tucker D., et al: Preliminary findings of antistreptococcal antibody titers and basal ganglia volume in tic obsessive-compulsive, and attention-deficit/ hyperactivity disorders. Arch Gen Psychiatry2000;57:364— 372.
47.
Betancourt YM , Jimenez-Leon JC, Jimenez-Betancourt CS, Castillo VE: Autoimmune neuropsychiatric disorders associated to infection by streptococcus in the paediatric age: PANDAS. Rev Neurol2003;36(Suppl 1):S95—S107.
48.
Singer HS, Giuliano JD, Hansen BH, et al: Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome. Biol Psychiatry1999;46:775—780.
49.
Loiselle CR , Wendlandt JT, Rohde CA, Singer HS: Antistreptococcal neuronal and nuclear antibodies in Tourette syndrome. Pediatr Neurol2003;28:119—125.
50.
Singer HS, Loiselle CR, Lee O., et al: Anti-basal ganglia autoantibodies in PANDAS. Mov Disord2004;19:406—415.
51.
Singer HS, Loiselle C.: PANDAS: A commentary. JPsychosom Res2003;55:31—39.
52.
Kurlan R., Kaplan EL: The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: Hypothesis or entity? Practical considerations for the clinician . Pediatrics2004;113:883—886.
53.
Singer HS, Giuliano JD, Hansen BH, et al: Antibodies against human putamen in children with Tourette syndrome . Neurology1998;50:1618—1624.
54.
Singer HS, Giuliano JD, Zimmerman AM, Walkup JT: Infection: A stimulus for tic disorders. Pediatr Neurol2000;22:380—383.
55.
Wendlandt JT , Grus FH, Hansen BH, Singer HS: Striatal antibodies in children with Tourette syndrome: Multivariate discriminant analysis of IgG repertories. J Neuroimmunol2001; 119:106—113.
56.
Martino D., Church AJ, Dale RC, Giovannoni G.: Antibasal ganglia antibodies and PANDAS. Mov Disord2005;20:116—117.
57.
Pavone P., Bianchini R., Parano E., et al: Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol2004;30:107—110.
58.
Martin JM, Green M., Barbadora KA, Wald ER: Group A streptococci among school-aged children: Clinical characteristics and the carrier state. Pediatrics2004;114:1212—1219.
59.
Kaplan EL, Wotton JT, Johnson DR: Dynamic epidemiology of group A streptococcus serotypes associated with pharyngitis . Lancet2001;358:1334—1337.
60.
Shulman ST, Tanz RR, Kabat W., et al: US Streptoccal Pharyngitis Surveillance Group. Group A streptoccal pharyngitis serotype surveillance in North America, 2001-2002. Clin Infect Dis2004;39: 325—332.
61.
D'Arca As, Tarsitani G., Bellante G., et al: Prevalenza e persistenza dello stato di portatore di streptococco A beta-emolitico. Nota 1: Indagine in collettività scolari Roma. Nuovi Ann Ig Microbiol1982 ;33:3—22.
62.
Principi N. , Marchisio P.: Incidence of severe streptococcal-related diseases in Italian children in an era of high group A streptococcal resistance to macrolides. Italian Group A Streptococcal Resistance to Macrolides Study Group. J Chemother1999;11:379—384.
